Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1825 1
1846 1
1847 1
1849 1
1852 1
1853 1
1867 1
1871 2
1877 1
1878 1
1879 2
1881 2
1883 1
1884 1
1885 1
1886 1
1887 9
1888 2
1889 2
1890 4
1891 1
1892 1
1893 1
1894 2
1895 4
1896 1
1897 4
1898 6
1899 3
1900 1
1901 3
1902 3
1903 3
1904 5
1905 5
1906 3
1907 5
1908 6
1909 4
1910 5
1911 8
1912 11
1913 8
1914 7
1915 16
1916 10
1917 5
1918 2
1919 9
1920 4
1921 9
1922 4
1923 7
1924 6
1925 6
1926 10
1927 3
1928 3
1929 4
1930 8
1931 3
1932 6
1933 8
1934 4
1935 8
1936 9
1937 5
1938 16
1939 10
1940 7
1941 3
1942 11
1943 5
1944 4
1945 183
1946 533
1947 595
1948 664
1949 422
1950 476
1951 1709
1952 2869
1953 3136
1954 3428
1955 3672
1956 3765
1957 3989
1958 3745
1959 2230
1960 898
1961 1032
1962 1432
1963 3098
1964 10128
1965 17547
1966 22268
1967 28175
1968 31805
1969 35275
1970 37173
1971 40601
1972 43989
1973 47537
1974 49075
1975 49546
1976 49336
1977 49644
1978 51516
1979 54474
1980 55627
1981 56542
1982 60533
1983 63316
1984 66888
1985 69764
1986 72558
1987 74554
1988 77997
1989 84573
1990 88839
1991 88074
1992 89910
1993 91741
1994 92414
1995 95938
1996 97655
1997 98880
1998 104270
1999 107466
2000 115046
2001 120812
2002 128398
2003 137367
2004 143513
2005 155821
2006 166594
2007 174351
2008 181955
2009 187064
2010 199872
2011 212878
2012 224847
2013 233010
2014 239766
2015 242693
2016 242680
2017 243167
2018 247746
2019 255383
2020 274886
2021 272215
2022 231614
2023 212837
2024 106362
2025 6

Text availability

Article attribute

Article type

Publication date

Search Results

6,683,453 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for drug a
Search for Druc A instead (3 results)
An Overview of Drug Delivery Systems.
Jain KK. Jain KK. Methods Mol Biol. 2020;2059:1-54. doi: 10.1007/978-1-4939-9798-5_1. Methods Mol Biol. 2020. PMID: 31435914 Review.
This is an overview of the current drug delivery systems (DDSs) starting with various routes of drug administration. Various drug formulations are then described as well as devices used for drug delivery and targeted drug delivery. ...
This is an overview of the current drug delivery systems (DDSs) starting with various routes of drug administration. Various …
Drug ratio-dependent antagonism: a new category of multidrug resistance and strategies for its circumvention.
Harasym TO, Liboiron BD, Mayer LD. Harasym TO, et al. Methods Mol Biol. 2010;596:291-323. doi: 10.1007/978-1-60761-416-6_13. Methods Mol Biol. 2010. PMID: 19949929 Review.
A newly identified form of multidrug resistance (MDR) in tumor cells is presented, pertaining to the commonly encountered resistance of cancer cells to anticancer drug combinations at discrete drug:drug ratios. In vitro studies have revealed that whether anti …
A newly identified form of multidrug resistance (MDR) in tumor cells is presented, pertaining to the commonly encountered resistance of canc …
A guide to drug discovery: Target selection in drug discovery.
Knowles J, Gromo G. Knowles J, et al. Nat Rev Drug Discov. 2003 Jan;2(1):63-9. doi: 10.1038/nrd986. Nat Rev Drug Discov. 2003. PMID: 12509760 Review.
Target selection in drug discovery--defined here as the decision to focus on finding an agent with a particular biological action that is anticipated to have therapeutic utility--is influenced by a complex balance of scientific, medical and strategic considerations. ...
Target selection in drug discovery--defined here as the decision to focus on finding an agent with a particular biological action tha …
Prevalence of potential drug-drug interactions in outpatients of a general hospital in China: a retrospective investigation.
Ren W, Liu Y, Zhang J, Fang Z, Fang H, Gong Y, Lv X. Ren W, et al. Int J Clin Pharm. 2020 Aug;42(4):1190-1196. doi: 10.1007/s11096-020-01068-3. Epub 2020 Jun 3. Int J Clin Pharm. 2020. PMID: 32488437 Free PMC article.
Background Potential drug-drug interactions are important factors resulting in adverse drug reactions or therapeutic failure. Therefore, potential drug-drug interactions need to be identified to prevent the related risk and improve drug s …
Background Potential drug-drug interactions are important factors resulting in adverse drug reactions or therapeutic fa …
Neutrophilic drug reactions.
Coromilas AJ, Gallitano SM. Coromilas AJ, et al. Clin Dermatol. 2020 Nov-Dec;38(6):648-659. doi: 10.1016/j.clindermatol.2020.06.012. Epub 2020 Jul 5. Clin Dermatol. 2020. PMID: 33341199 Review.
Neutrophilic drug reactions are unique eruptions that can affect hospitalized patients and share a common pathophysiology with neutrophils as the key mediators of inflammation. ...There are limited prospective observational studies dedicated to these adverse drug re …
Neutrophilic drug reactions are unique eruptions that can affect hospitalized patients and share a common pathophysiology with neutro …
Potential Drug-Drug Interactions Between Anti-Cancer Drugs and Other Medications in Lung Cancer Patients: A Retrospective Study.
Pinto RA, Rao M, Roy A, Thomas L, Udupa KS, Guddattu V. Pinto RA, et al. Curr Drug Saf. 2023;18(2):175-189. doi: 10.2174/1574886317666220324100356. Curr Drug Saf. 2023. PMID: 35331122
The oral chemotherapeutic drug gefitinib was found to be associated with the highest number of drug-drug interactions. CONCLUSION: Drug-drug interactions were highly prevalent among hospitalized lung cancer patients. ...
The oral chemotherapeutic drug gefitinib was found to be associated with the highest number of drug-drug interactions. …
Ex Vivo Metrics, a preclinical tool in new drug development.
Curtis CG, Bilyard K, Stephenson H. Curtis CG, et al. J Transl Med. 2008 Jan 23;6:5. doi: 10.1186/1479-5876-6-5. J Transl Med. 2008. PMID: 18215298 Free PMC article. Review.
Among the challenges facing translational medicine today is the need for greater productivity and safety during the drug development process. To meet this need, practitioners of translational medicine are developing new technologies that can facilitate decision making duri …
Among the challenges facing translational medicine today is the need for greater productivity and safety during the drug development …
6,683,453 results
You have reached the last available page of results. Please see the User Guide for more information.